A new suggested strategy for safe injection of ozurdex

Chelsey J. Krambeer, Kendall W. Wannamaker, Wayne Tie, Sepehr Bahadorani, Julia Singer, Stan Conston, Michael A. Singer

Resultado de la investigación: Articlerevisión exhaustiva

1 Cita (Scopus)


BACKGROUND AND OBJECTIVES: Ozurdex intravitreal injection is performed via a patented injection device. However, there is a common misconception among ophthalmologists regarding the relation between the speed of applicator button depression and the speed of pellet injection. PATIENTS AND METHODS: Six dexamethasone intravitreal implants were injected into a calibrated ex vivo water bath. Three of the pellets were injected via rapid compression, whereas the other three implants were injected using a 3-second compression technique. The procedures were recorded using high-speed photography followed by calculation of pellet velocity and impact force. RESULTS: The mean impact velocity and force of the pellet insertion is significantly higher in the fast injection group compared to the slow injection group. CONCLUSIONS: By depressing the Ozurdex implant injector during a 3-second time interval, the impact force of the implant pellet is reduced by about 95%. This new technique will theoretically reduce the risk of retinal injury and vitreous hemorrhage from Ozurdex injections.

Idioma originalEnglish (US)
Páginas (desde-hasta)E23-E25
PublicaciónOphthalmic Surgery Lasers and Imaging Retina
EstadoPublished - feb 2019

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology


Profundice en los temas de investigación de 'A new suggested strategy for safe injection of ozurdex'. En conjunto forman una huella única.

Citar esto